Address
Seocho-daero, Seoul, South Korea

Work Hours
Monday to Friday: 10AM - 5PM KST
Weekend, Holiday: OFF

Botulax 300IU (10 Set)

Original price was: $750.Current price is: $620.

10 Set of Botulax 300IU

Botulax 300 Units, a potent type A toxin, offers a revolutionary approach to wrinkle reduction and facial muscle activity correction. Administered via intramuscular injection, it temporarily and reversibly suppresses muscle activity, effectively eliminating expression lines.

Component: Botulinum toxin type A

Package Unit: 1 Vial / BOX

Category: Tags: , , ,

BOTULAX 100 Units Overview

BOTULAX is a muscle relaxant containing purified botulinum toxin type A combined with haemagglutinin and sodium chloride. Its mechanism of action involves blocking nerve impulses, disrupting acetylcholine synthesis, and temporarily paralyzing facial muscles to smooth wrinkles.

Active Ingredient:

  • Clostridium botulinum toxin type A
  • Strain: Clostridium botulinum CBFC26
  • Dose: 300 units (IU)

Mode of Action:

  • Type A botulinum toxin inhibits nerve signals to muscles, reducing their ability to contract and thereby minimizing wrinkles.
  • Used for forehead lines, crow’s feet, lion’s wrinkles, and horizontal and vertical neck wrinkles, as well as for lip contour correction.

Strengths:

  • quick action
  • lasting effect
  • excellent patient tolerance
  • selective corrective action provides a natural effect
  • this is a complete analog of Botox at affordable prices

Scope:

  • smoothing vertical wrinkles in the area of ​​the eyebrows
  • elimination of crow’s feet (injections into the circular eye muscles)
  • elimination of wrinkles near the mouth, correction of the shape of the lips (caused by spasms)
  • correction of Venus’s rings
  • correction of blepharospasm
  • elimination of hyperhidrosis
  • botox-lifting

Duration:

The duration of the effect of 4-6 months.

Product composition:

Botulinum toxin type A, Saline 0.9%, NaCl 20ml – 1ea

Packaging:

1 vial, 300 units per pack / Weight: 30 g

Manufacturer:

Hugel pharma co. ltd, South Korea